Gene Disease Score gda Association Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A
CUI: C1608408
Disease: Malignant transformation
Malignant transformation
0.100 Biomarker BEFREE Candidate markers of malignant transformation include p16, HMB45, and Ki-67, with p16 being of particular interest. 30887559

2019

Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A
CUI: C1608408
Disease: Malignant transformation
Malignant transformation
0.100 Biomarker BEFREE Cdkn2a (Arf) loss drives NF1-associated atypical neurofibroma and malignant transformation. 31091306

2019

Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A
CUI: C1608408
Disease: Malignant transformation
Malignant transformation
0.100 PosttranslationalModification BEFREE A similar effect of P16 hydroxymethylation and true-methylation on the prediction of malignant transformation of oral epithelial dysplasia: observation from a prospective study. 30249192

2018

Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A
CUI: C1608408
Disease: Malignant transformation
Malignant transformation
0.100 AlteredExpression BEFREE Study on expression of p16 and human papillomavirus 16 and 18 (E6) in OLP and its malignant transformation. 29254790

2018

Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A
CUI: C1608408
Disease: Malignant transformation
Malignant transformation
0.100 AlteredExpression BEFREE The aim of the study was to analyze the correlation between the expression of p16 as a surrogate of HPV infection in analyzed histopathological material and epidemiological variables, recurrences or malignant transformation. 28479047

2018

Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A
CUI: C1608408
Disease: Malignant transformation
Malignant transformation
0.100 GeneticVariation BEFREE The majority (5/8) of MPNSTs in our analyses demonstrated homozygous or heterozygous deletions of CDKN2A, which may represent an early event following NF1 LOH in the malignant transformation of Schwann cells from plexiform neurofibroma to MPNST. 28124441

2017

Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A
CUI: C1608408
Disease: Malignant transformation
Malignant transformation
0.100 Biomarker BEFREE The expression of the nuclear and cytoplasmic forms of p16 represent two independent mechanisms, and both seemed to control proliferation in response to oncogenic stimuli, protecting the cell from malignant transformation in BRAF-mutated GISTs. 28034324

2017

Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A
CUI: C1608408
Disease: Malignant transformation
Malignant transformation
0.100 GeneticVariation BEFREE Our study suggests that: (1) polysomy 6 and p16 deletion may contribute to adenomatous change of IPMN; (2) polysomy 7, polysomy 18, p16 deletion, and p53 deletion play roles in malignant transformation of noninvasive IPMN; and (3) polysomy 7 and p53 deletion may be excellent diagnostic markers for invasive IPMN. 25517961

2015

Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A
CUI: C1608408
Disease: Malignant transformation
Malignant transformation
0.100 GeneticVariation BEFREE In mouse melanoma models with specific induced gene mutations including mutations of the Braf, Pten, and Cdkn2a genes, viral infection correlated with the extent of malignant transformation. 23552414

2013

Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A
CUI: C1608408
Disease: Malignant transformation
Malignant transformation
0.100 GeneticVariation BEFREE Methylation of the DAPK and p16 genes, although not sufficient to dictate prognosis of the disease, should not be underestimated because it may form part of a process of genetic and epigenetic alterations that in the future could become relevant to malignant transformation. 22371043

2012

Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A
CUI: C1608408
Disease: Malignant transformation
Malignant transformation
0.100 Biomarker BEFREE It has been shown that the induction of p16(Ink4a) in premalignant lesions and its loss during malignant transformation is an important mechanism in the carcinogenesis of several tumours. 21423154

2011

Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A
CUI: C1608408
Disease: Malignant transformation
Malignant transformation
0.100 PosttranslationalModification BEFREE To investigate the p16 protein expression and promoter methylation of p16 gene in Ca-ex-PA and their roles in the malignant transformation of pleomorphic adenoma to Ca-ex-PA. 21732778

2011

Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A
CUI: C1608408
Disease: Malignant transformation
Malignant transformation
0.100 GeneticVariation BEFREE AID-mediated genotoxic effects appear to occur frequently at the CDKN2b-CDKN2a locus and contribute to malignant transformation of the gastric mucosa. 20637757

2010

Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A
CUI: C1608408
Disease: Malignant transformation
Malignant transformation
0.100 Biomarker BEFREE These results imply that alterations of the cell-cycle checkpoint controlling proteins p27(KIP1), p16(INK4a), and RB1 may exert a profound effect in malignant transformation in BPDCN. 19924135

2010

Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A
CUI: C1608408
Disease: Malignant transformation
Malignant transformation
0.100 AlteredExpression BEFREE HMEC that express p16INK4A and vHMEC that do not, were transduced with constitutively active Ha-rasV12 and subsequently exposed to serum to determine whether signals from the cellular microenvironment could cooperate with ras to promote the malignant transformation of vHMEC. 19995452

2009

Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A
CUI: C1608408
Disease: Malignant transformation
Malignant transformation
0.100 Biomarker BEFREE JunB is an essential upstream regulator of p16 and contributes to maintain cell senescence that blocks malignant transformation of TAC. 18628455

2008

Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A
CUI: C1608408
Disease: Malignant transformation
Malignant transformation
0.100 PosttranslationalModification BEFREE We thus conclude that methylation of the p16 gene promoter shows promise as a predictor for malignant transformation (Fisher's exact, P = 0.002) in a subset of patients. 18708411

2008

Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A
CUI: C1608408
Disease: Malignant transformation
Malignant transformation
0.100 Biomarker BEFREE Inactivation of the p16(INK4a)/Rb pathway may allow continuous cell division and critical telomere shortening, which induce genome instability, finally leading to malignant transformation. 17428253

2007

Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A
CUI: C1608408
Disease: Malignant transformation
Malignant transformation
0.100 AlteredExpression BEFREE Inactivation of myocardin and p16 during malignant transformation contributes to a differentiation defect. 17292825

2007

Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A
CUI: C1608408
Disease: Malignant transformation
Malignant transformation
0.100 Biomarker BEFREE Deletions of RB1 and/or CDKN2A were observed in 71% of LGGs and in 90% of tumors after MT. 17308273

2007

Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A
CUI: C1608408
Disease: Malignant transformation
Malignant transformation
0.100 Biomarker BEFREE Methylation of p16 and Ras association domain family protein 1a during colorectal malignant transformation. 16687485

2006

Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A
CUI: C1608408
Disease: Malignant transformation
Malignant transformation
0.100 GeneticVariation BEFREE We also examined deletion of cyclin-dependent kinase inhibitor 4 (INK4) genes and mutation of p53 gene in combination with changes in the HTLV-I genome in acute type ATL to test whether host genetic changes promoted the malignant transformation of ATL cells that carry putative CTL escape mutations. 16052518

2006

Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A
CUI: C1608408
Disease: Malignant transformation
Malignant transformation
0.100 Biomarker BEFREE It has been suggested that the up-regulation of the tumour suppressor p16 gene and induction of senescence protect the phenotype of psoriatic involved skin from malignant transformation. 16552541

2006

Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A
CUI: C1608408
Disease: Malignant transformation
Malignant transformation
0.100 Biomarker BEFREE Transcriptional programs following genetic alterations in p53, INK4A, and H-Ras genes along defined stages of malignant transformation. 15930270

2005

Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A
CUI: C1608408
Disease: Malignant transformation
Malignant transformation
0.100 Biomarker BEFREE These results suggest that loss of p16(INK4A) gene on 9p may contribute to the progression and/or malignant transformation of GISTs. 15181453

2004